⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Cannabis Use Disorder in Multiple Sclerosis: Characterization of a National Sample of Patients Seeking Treatment (P2-6.006)

Shayna Pehel Timothy Ko Luis E. Fernandez Erica Kreisberg Matthew Lustberg Giuseppina Pilloni Leigh Charvet

View Full Paper

Ask AI

Bookmark

Share

Abstract

To characterize a national sample of patients with multiple sclerosis (MS) seeking to enroll in a clinical trial of a telehealth intervention for cannabis use disorder (CUD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pehel et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db6435876773c2 https://doi.org/10.1212/wnl.0000000000205310

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Emerging pharmacotherapy for the treatment of cannabis use disorder2024 · 1 citations
2CANNABIS USE DISORDER TREATMENT PREFERENCES: A PILOT SURVEY IN CURRENT USERS OF CANNABIS2025
3Cannabis Use Disorder as a disorder of motivational dysregulation: a systematic review of clinical, neurocognitive, and treatment evidenceSystematic Review · 2026 · 1 citations
4A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol2024 · 10 citations
5Taxonicity of Cannabis Use Disorder: Findings from Nationally Representative Community Sample and an Inpatient Clinical Sample2024